Back to mobile site

Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Wells Fargo

October 13, 2026 5:55 AM EDT Send to a Friend
Wells Fargo analyst Mohit Bansal lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $65.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login